Zydus Lifesciences share news, announcements and annual reports
NSE: ZYDUSLIFEBSE: 532321Pharmaceuticals & BiotechnologyMid Cap
Zydus Lifesciences Limited · Formerly Cadila Healthcare · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 2000
Last close ₹1,245.50up ₹61.10 (5.16%)BSE ₹1,244.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,184.40.
30 Oct: open ₹1,190.00, high ₹1,248.90, low ₹1,182.00
52-week range of traded prices to 30 Oct 2026
₹835.50Low, 2 Apr 2026₹1,248.90High, 30 Oct 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,24,239 Cr114th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 27.53
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹535 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 24.61
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.58
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.08%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹535 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 19.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 15.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 36,60,70935.2% delivered
Zydus Lifesciences analyst meets
100 filed, newest first. Page 2 of 2.
Sep 2022
Aug 2022
5 Aug · Analysts
Jul 2022
1 Jul · Analysts
Jun 2022
6 Jun · Analysts
May 2022
16 May · Analysts
16 May · Analysts
Jan 2022
29 Jan · Analysts
Dec 2021
10 Dec · Analysts
Nov 2021
15 Nov · Analysts
Oct 2021
29 Oct · Analysts
29 Oct · Analysts
23 Oct · Analysts
Sep 2021
14 Sep · Analysts
3 Sep · Analysts
Aug 2021
23 Aug · Analysts
20 Aug · Analysts
6 Aug · Analysts
May 2021
24 May · Analysts
21 May · Analysts
12 May · Analysts
Feb 2021
25 Feb · Analysts
24 Feb · Analysts
1 Feb · Analysts
Dec 2020
23 Dec · Analysts
Oct 2020
31 Oct · Analysts
26 Oct · Analysts
Sep 2020
2 Sep · Analysts
Aug 2020
31 Aug · Analysts
Jul 2020
28 Jul · Analysts
Jun 2020
17 Jun · Analysts
Mar 2020
20 Mar · Analysts
Jan 2020
29 Jan · Analysts
Nov 2019
6 Nov · Analysts
Jul 2019
31 Jul · Analysts
May 2019
21 May · Analysts
Feb 2019
2 Feb · Analysts
Oct 2018
24 Oct · Analysts
Aug 2018
1 Aug · Analysts
May 2018
16 May · Analysts
16 May · Analysts
Jan 2018
31 Jan · Analysts
Nov 2017
2 Nov · Analysts
Aug 2017
1 Aug · Analysts
May 2017
18 May · Analysts
Jan 2017
19 Jan · Analysts
Nov 2016
15 Nov · Analysts
Oct 2016
19 Oct · Analysts
Jul 2016
May 2016